onr:"swepub:oai:DiVA.org:liu-96420"
Search: onr:"swepub:oai:DiVA.org:liu-96420" > Infliximab as rescu...
- 1 of 1
- Previous record
- Next record
- To hitlist
Infliximab as rescue therapy in hospitalised patients with steroid-refractory acute ulcerative colitis: a long-term follow-up of 211 Swedish patients
-
- Sjöberg, Mats (author)
- Örebro universitet,Institutionen för hälsovetenskap och medicin,Skaraborgs Hospital, Lidköping, Sweden
-
- Magnuson, A (author)
- Clinical Epidemiology and Biostatistics Unit, Örebro University Hospital, Örebro, Sweden
-
- Bjork, J (author)
- Department of Gastroenterology and Hepatology, Karolinska University Hospital, Stockholm, Sweden
- show more...
- show less...
- (creator_code:org_t)
- 2013-06-25
- 2013
- English.
- In: Alimentary Pharmacology and Therapeutics. - : Wiley-Blackwell. - 0269-2813 .- 1365-2036. ; 38:4, s. 377-387
- Journal article (peer-reviewed)
Abstract
Subject headings
Close
- BackgroundRescue therapy with infliximab (IFX) has been proven effective in a steroid-refractory attack of ulcerative colitis (UC). The long-term efficacy is not well described. less thanbrgreater than less thanbrgreater thanAimTo present a retrospective study of IFX as rescue therapy in UC. Primary end points were colectomy-free survival at 3 and 12months. less thanbrgreater than less thanbrgreater thanMethodsIn this multicentre study, 211 adult patients hospitalised between 1999 and 2010 received IFX 5mg/kg as rescue therapy due to a steroid-refractory, moderate-to-severe attack of UC. Exclusion criteria were duration of current flare for andgt;12weeks, corticosteroid treatment for andgt;8weeks before hospitalisation, previous IFX therapy or Crohns disease. less thanbrgreater than less thanbrgreater thanResultsProbability of colectomy-free survival at 3months was 0.71 (95% CI, 0.64-0.77), at 12months 0.64 (95% CI, 0.57-0.70), at 3years 0.59 (95% CI, 0.52-0.66) and at 5years 0.53 (95% CI, 0.44-0.61). Steroid-free, clinical remission was achieved in 105/211 (50%) and 112/209 (54%) patients at 3 and 12months respectively. Of 75 colectomies during the first year, 48 (64%) were carried out during the first 14days, 13 (17%) on days 15-90 and 14 (19%) between 3 and 12months. There were three (1.4%) deaths during the first 3months. less thanbrgreater than less thanbrgreater thanConclusionsInfliximab is an effective rescue treatment, both short- and long-term, in a steroid-refractory attack of UC. Most IFX failures underwent surgery during the first 14days, which calls for studies on how to optimise induction treatment with IFX. Serious complications, including mortality, were rare.
Subject headings
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Gastroenterologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Gastroenterology and Hepatology (hsv//eng)
Keyword
- MEDICINE
- MEDICIN
- Medicine
Publication and Content Type
- ref (subject category)
- art (subject category)
Find in a library
- Alimentary Pharmacology and Therapeutics (Search for host publication in LIBRIS)
To the university's database
- 1 of 1
- Previous record
- Next record
- To hitlist
Find more in SwePub
- By the author/editor
- Sjöberg, Mats
- Magnuson, A
- Bjork, J
- Benoni, Cecilia
- Almer, Sven
- Friis-Liby, I
- show more...
- Hertervig, Erik
- Olsson, M
- Karlen, P
- Eriksson, A
- Midhagen, Gunnar
- Carlson, Marie
- Lapidus, A
- Halfvarson, Jona ...
- Tysk, Curt
- show less...
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
- MEDICAL AND HEAL ...
- and Clinical Medicin ...
- and Gastroenterology ...
- Articles in the publication
- Alimentary Pharm ...
Search outside SwePub
- Extend your search to:
- Google Book Search
- Google Scholar
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
- Copyright © LIBRIS - National Library Systems
- LIBRIS.kb.se
